Trade Summary

5 days ago, Warmuth Markus, serving as President & CEO at Monte Rosa Therapeutics, Inc. (GLUE), sold 9,500 shares at $23.18 per share, for a total transaction value of $220,218.55. Following this transaction, Warmuth Markus now holds 585,038 shares of GLUE.

This sale represents a 1.60% decrease in Warmuth Markus's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 16, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 17, 2026 at 4:05 PM ET, 1 day after the trade was made.

Monte Rosa Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.